Xeris Pharmaceuticals Inc (XERS) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $6.74
• Market Cap: $1.11B
• EPS: $-0.10
• 52-Week High: $10.08
• 52-Week Low: $3.59

Market Sentiment

Xeris Pharmaceuticals Inc currently has a Bearish sentiment score of -0.16.

About Xeris Pharmaceuticals Inc

Xeris Pharmaceuticals, Inc. is a pioneering specialty pharmaceutical company headquartered in Chicago, Illinois, dedicated to the development and commercialization of ready-to-use injectable and infusible drug formulations. Utilizing its proprietary formulation technology, Xeris enhances patient care by improving the delivery and efficacy of therapeutics across critical therapeutic areas, including diabetes and oncology. The company is strategically positioned to address unmet medical needs, ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Xeris Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does XERS pay dividends?

Xeris Pharmaceuticals Inc (XERS) does not currently pay a regular dividend.

What is XERS's market cap?

Xeris Pharmaceuticals Inc (XERS) has a market capitalization of $1.11B with a current stock price of $6.74.